Compare Enveric Biosciences Inc (ENVB) vs Gitlab Inc (GTLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Gitlab Inc — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Gitlab Inc trades at $31.94 (market cap $5.54B). The key difference: Gitlab Inc is far larger — about 1041.4× Enveric Biosciences Inc's market cap, and Gitlab Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | GTLB | |
|---|---|---|
Market Cap | $5.32M | $5.54B |
Sector | Health | Technology |
52-Week High | $17.40 | $51.04 |
52-Week Low | $1.28 | $19.42 |
Enterprise Value | $408.82K | $4.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Gitlab Inc
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →
